PD-1+VEGF bsAb
Bispecific antibody Phase I Global  (except China) Oncology/Cancer
Boston
|
San Jose
|
Newark
|
Frankfurt
London
|
Basel
|
Beijing
|
Shanghai
Hangzhou
|
Suzhou
Stay Connected and Get Updates
Subscribe newsletter